MARKET

CCM

CCM

Concord Med
NYSE

Real-time Quotes | Nasdaq Last Sale

3.016
+0.116
+3.99%
Opening 12:14 09/16 EDT
OPEN
2.880
PREV CLOSE
2.900
HIGH
3.080
LOW
2.880
VOLUME
4.02K
TURNOVER
--
52 WEEK HIGH
5.89
52 WEEK LOW
1.680
MARKET CAP
130.92M
P/E (TTM)
-3.1325
1D
5D
1M
3M
1Y
5Y
BRIEF-Concord Medical Purchases Additional Proton Therapy System For It's Shanghai Concord Cancer Center
reuters.com · 6d ago
Kadmon, ICU Medical leads healthcare gainers; INmune Bio, Inozyme Pharma among major losers
Gainers: Kadmon (NASDAQ:KDMN) +73%, ICU Medical (NASDAQ:ICUI) +32%, Candel Therapeutics (NASDAQ:CADL) +17%, Gain Therapeutics (NASDAQ:GANX) +9%, Concord Medical Services (NYSE:CCM) +9%. Losers: INmune Bio (NASDAQ:INMB) -22%, Inozyme Pharma (NASDAQ:INZY) -1...
Seekingalpha · 09/08 14:58
Concord Medical Completes RMB 400 Million Funding Round Led by Consortium Investors
Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializes in cancer treatment, research, education, and prevention by establishing proton centers and specialty cancer hospitals and operati...
PR Newswire · 08/23 10:10
Concord Medical Officially Opens New Specialty Cancer Hospital in Guangzhou
Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalon...
PR Newswire · 06/11 10:11
Concord Medical Services' Specialty Cancer Hospital in China Commences Operations
MT Newswires · 06/11 06:38
75 Biggest Movers From Yesterday
Gainers Clover Health Investments, Corp. (NASDAQ: CLOV) shares surged 85.8% to close at $22.15 on Tuesday amid increased retail investor interest in the stock.
Benzinga · 06/09 09:01
Concord Medical receives deficiency notice from NYSE over delayed filing
Concord Medical (CCM) has received notice from NYSE that the delay in filing its annual report on Form 20-F for the fiscal year ended December 31, 2020 does not meet its listing requirement
Seekingalpha · 05/25 10:22
Concord Medical Receives Notification from NYSE Regarding Delayed Filing of 2020 Annual Report
, /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hosp...
PR Newswire - PRF · 05/25 10:03
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CCM. Analyze the recent business situations of Concord Med through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Underperform

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CCM stock price target is 1.200 with a high estimate of 1.200 and a low estimate of 1.200.
EPS
Institutional Holdings
Institutions: 11
Institutional Holdings: 734.88K
% Owned: 1.69%
Shares Outstanding: 43.41M
TypeInstitutionsShares
Increased
1
3.91K
New
0
0
Decreased
3
117.19K
Sold Out
2
1.04K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
+0.11%
Healthcare Providers & Services
-0.13%
Key Executives
Chairman/Chief Executive Officer/Director
Jianyu Yang
President/Chief Financial Officer
Yaw Kong Yap
Chief Operating Officer
Fu Xiao
Other
Matthew Callister
Director
Zheng Cheng
Director
Yue Yu
Independent Director
Weibo Yin
Independent Director
Boxun Zhang
Independent Director
Liping Zhang
Declaration Date
Dividend Per Share
Ex-Div Date
12/11/2015
Dividend USD 0.99
12/23/2015
07/28/2014
Dividend USD 0.9
08/05/2014
01/07/2014
Dividend USD 0.72
01/16/2014
08/12/2011
Dividend USD 0.18
08/29/2011
  • All
  • Financials
  • Insiders
More
About CCM
Concord Medical Services Holdings Limited is engaged in the leasing of radiotherapy and diagnostic imaging equipment, the provision of management services to hospitals. The Company is also engaged in hospital operations. The Company's segments are network and premium cancer hospital. The Company operates a network of radiotherapy and diagnostic imaging centers in China. Its network consists of approximately 130 cooperative centers based in over 70 hospitals, spanning approximately 60 cities across 25 provinces and administrative regions in China. Its network includes approximately 60 radiotherapy centers and over 60 diagnostic imaging centers and approximately seven centers. The Company's cooperative centers are equipped with a primary unit of medical equipment, such as a linear accelerator, head gamma knife system, body gamma knife system, positron emission tomography-computed tomography (PET-CT) scanner or magnetic resonance imaging (MRI) scanner.

Webull offers kinds of Concord Medical Services Hldg Ltd (ADR) stock information, including NYSE:CCM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CCM stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CCM stock methods without spending real money on the virtual paper trading platform.